GoldMiner Search
 
J Nucl Med 2016; 57:1560-1568<br/><hr/><font size=1>Findings of blood flow confined primarily to posterior fossa on blood flow study using lipophilic radiopharmaceutical in 24-y-old man who fell down flight of ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:1560-1568<br/><hr/><font size=1>Findings of absence of blood flow on blood flow study using lipophilic radiopharmaceutical in 33-y-old man after hanging. (A) CT scan demonstrates diffuse cerebral ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:1560-1568<br/><hr/><font size=1>Findings of persistence of blood flow on blood flow study using lipophilic radiopharmaceutical in 18-y-old man after motor vehicle accident followed by left-sided craniotomy ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:1560-1568<br/><hr/><font size=1>Findings of absence of blood flow on blood flow study using nonlipophilic radiopharmaceutical TcO-99m4 in 28-y-old woman with diffuse cerebral edema due to hypoxic ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:1560-1568<br/><hr/><font size=1>Findings of persistence of blood flow on blood flow study using nonlipophilic radiopharmaceutical in 22-y-old man with ruptured aneurysm of left posterior inferior cerebral ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:90S-96S<br/><hr/><font size=1>Detection of wide variety of PC lesions with F-18-DCFPyL. Locally recurrent PC (CT [A] and F-18-DCFPyL PET/CT [B]) and lymph node (CT [C] and ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:55S-60S<br/><hr/><font size=1>F-18-NaF PET/CT and F-18-fluorocholine (FCH) PET/CT images in intermediate-risk prostate cancer patient after radiation therapy on vertebral spine (T10). Negative F-18-NaF and F-18-fluorocholine PET ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:55S-60S<br/><hr/><font size=1>Comparison of F-18-fluorocholine (FCH) and F-18-NaF PET/CT images in prostate cancer patient (prostate-specific antigen level, 7.3 ng/mL; Gleason score, 7). F-18-NaF PET scan shows ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:55S-60S<br/><hr/><font size=1>Comparison of F-18-fluorocholine (FCH) and F-18-NaF images in high-risk prostate cancer patient after hormone therapy. F-18-NaF PET image shows significantly increased tracer uptake on ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:55S-60S<br/><hr/><font size=1>Follow-up F-18-fluorocholine (FCH) PET images of high-risk prostate cancer patient. Suspiciously increased tracer uptake on lumbar spine (upper row left, arrow) without any morphologic ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:25S-29S<br/><hr/><font size=1>69-y-old man with castration-resistant metastatic prostate cancer before (A and B) and after (C and D) treatment with docetaxel. Note general decline in metabolic ...</font>

J Nucl Med 2016

J Nucl Med 2017; 58:1545-1552<br/><hr/><font size=1>Ga-68-PSMA ligand PET/CT scan exhibiting moderate, focal PSMA ligand uptake in left rib on transaxial PET (B) and fused PET/CT (D) images. (A and ...</font>

J Nucl Med 2017

J Nucl Med 2017; 58:1545-1552<br/><hr/><font size=1>Transaxial CT (A), PET (B), and fused PET/CT (C) Ga-68-PSMA ligand scans demonstrating moderate, focal PSMA ligand uptake (arrows) in comma-shaped soft-tissue structure between ...</font> J Nucl Med 2017
J Nucl Med 2017; 58:1545-1552<br/><hr/><font size=1>A 78-y-old patient with biochemical recurrence (PSA of 0.54 ng/mL) after radical prostatectomy (initially pT3b N0 M0 R0 G2). Ga-68-PSMA ligand PET/CT reveals focal ...</font> J Nucl Med 2017
J Nucl Med 2017; 58:1545-1552<br/><hr/><font size=1>A 63-y-old patient with biochemical recurrence (PSA of 0.21 ng/mL) after radical prostatectomy (initially pT2c N0 M0 L1/V1 R1 G1, Gleason score of 7), ...</font> J Nucl Med 2017
J Nucl Med 2016; 57:19S-24S<br/><hr/><font size=1>73-y-old man with PC. (A and B) Tc-99m-MDP bone scan was negative (A), whereas F-18-NaF PET/CT revealed single L4 metastasis (B). (C and D) ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:38S-42S<br/><hr/><font size=1>71-y-old patient who had suspected PC and unclear (BS-negative) vertebral bone lesions and was referred for F-18-choline PET/CT for initial staging before treatment. F-18-choline ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:38S-42S<br/><hr/><font size=1>52-y-old patient who had biopsy-proven high-risk PC (Gleason score, 4 + 5 = 9; prostate-specific antigen level, 84.4 ng/mL) and was referred for F-18-choline ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:38S-42S<br/><hr/><font size=1>71-y-old patient who had suspected PC (prostate-specific antigen level, 11.4 ng/mL) and was referred for F-18-choline PET/CT. F-18-choline PET/CT showed right-side focal uptake in ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:1635-1641<br/><hr/><font size=1>Results generated by Burgos et al.  , Ta et al.  , and Andreasen et al.  , and LDM based on T1 ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:1635-1641<br/><hr/><font size=1>Results of 2 slices (A and B) generated using T1, T2, and T1 + T2 images. MAEs for the 2 slices obtained using T1/T2/T1 ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:1635-1641<br/><hr/><font size=1>CT prediction results by the proposed method. MAEs of 3 slices are 140, 85, and 53 HUs; PSNRs are 21.6, 22.5, and 24.7 dB; ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:1650-1653<br/><hr/><font size=1>Navigation of the FC. Video signal of the overhead camera of navigation system allows projection of SPECT/CT (A) or SPECT (B) onto the patient. ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:1523-1528<br/><hr/><font size=1>83-y-old woman with primary ER-positive/HER2-negative invasive ductal breast carcinoma. (A) Immunohistochemistry score of primary breast malignancy was 1+ (at 400 magnification), consistent with HER2-negative ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:1523-1528<br/><hr/><font size=1>38-year-old woman with primary ER-positive/HER2-negative invasive ductal breast carcinoma. (A) Immunohistochemistry score of primary breast malignancy was 1+ (at 400 magnification), consistent with HER2-negative ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:1523-1528<br/><hr/><font size=1>41-y-old woman with primary ER-positive, HER2-negative invasive ductal breast carcinoma and recurrence in thoracic nodes. (A) Immunohistochemistry score of primary breast malignancy was 1+ ...</font>

J Nucl Med 2016

J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Various subtle abnormalities on CT images obtained for attenuation correction: small hemangioma in body of T12 (yellow arrow), subcentimeter exophytic isodensity in right kidney ...</font>

J Nucl Med Technol 2017

J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient with history of achalasia who presented with chest pain. Raw SPECT image is unremarkable (left). CT images obtained for attenuation correction show significant ...</font>

J Nucl Med Technol 2017

J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient who presented with chest pain. Raw SPECT image is unremarkable (top left). CT image obtained for attenuation correction shows subcentimeter spiculated nodule in ...</font> J Nucl Med Technol 2017
J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient with large abdominal mass who presented for preoperative evaluation. Raw SPECT image shows large area of photopenia within abdomen (arrow, left). CT images ...</font> J Nucl Med Technol 2017
J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient with end-stage renal disease who presented for preoperative evaluation. Raw SPECT image demonstrates relative photopenia in liver (arrow, left). CT image shows polycystic ...</font> J Nucl Med Technol 2017
J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient with end-stage liver disease who presented for pretransplantation evaluation. Raw SPECT image shows areas of photopenia throughout abdomen (arrows, left). CT image shows ...</font> J Nucl Med Technol 2017
J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient with fatty liver disease. Raw SPECT image shows minimal uptake in liver (arrow, left). CT image shows diffuse fatty changes throughout liver (arrow, ...</font>

J Nucl Med Technol 2017

J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Male patient with end-stage liver disease who presented for pretransplantation evaluation. Raw SPECT image shows round areas of mildly increased uptake in chest (arrows, ...</font>

J Nucl Med Technol 2017

J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient who presented with chest pain. Raw SPECT image shows round area of increased uptake in right upper chest (arrow, left). Right-mediastinum mass is ...</font>

J Nucl Med Technol 2017

J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient who presented with chest pain. Raw SPECT image shows focus of uptake in anterior abdominal wall (red arrow, top left) and linear uptake ...</font>

J Nucl Med Technol 2017

J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient with abnormal tracer accumulation posterior to heart on raw SPECT images, more pronounced at rest than at stress (arrows, top). CT image shows ...</font> J Nucl Med Technol 2017
J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient who presented with chest pain. Raw SPECT image shows abnormal tracer accumulation in right chest (arrow, left). CT image demonstrates, in posterior right ...</font> J Nucl Med Technol 2017
J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Patient with history of carcinoid tumor who presented with chest pain. Raw SPECT image shows mass in right upper chest (arrow, top left). Contrast-enhanced ...</font> J Nucl Med Technol 2017
J Nucl Med Technol 2017; 45:175-180<br/><hr/><font size=1>Lung cancer patient who was being evaluated after undergoing left pneumonectomy. Reduced counts in left chest on raw SPECT image (arrow, left) correlate with ...</font> J Nucl Med Technol 2017

ARRS Member?

If you are...

If you aren't...

...so you can earn CME credit for your GoldMiner searches.

1 - 40 · Next »  
Copyright © 2017, American Roentgen Ray Society facebook.com/ARRSGoldMiner   @ARRS_GoldMiner ARRS GoldMiner® is a registered trademark of the American Roentgen Ray Society.